Please find enclosed Intimation w.r.t Participation in Investor Conference.
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma has disclosed schedules for two upcoming investor conferences under SEBI regulations. The first meeting is on May 29, 2026 with ICICI Securities India Investor Conference at Grand Hyatt, Santacruz. The second meeting is scheduled for June 8, 2026 with 360 ONE Capital (B&K) Annual Investor Conference. The company has clarified that all discussions during these meetings will be strictly based on already published information. This is a routine regulatory disclosure filed on May 19, 2026 under Regulation 30 of the SEBI Listing Regulations.
This is a standard investor relations disclosure with minimal direct impact on stock price. The company's clarification that discussions will be limited to publicly available information reduces concerns about selective disclosure.